Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 77 to 126 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 77\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, alpha isoform (pp2a, subunit a, pr65-alpha isoform) (pp2a, subunit a, r1-alpha isoform) (medium tumor antigen-associated 61 kda protein). [source:swissprot;acc:p30153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4612.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3093.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.49095\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 78\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclic-amp-dependent transcription factor atf-3 (activating transcription factor 3). [source:swissprot;acc:p18847]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4800.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7132.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.48573\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 79\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein cgi-126 (protein hspc155). [source:swissprot;acc:q9y3c8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3074.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4567.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.48558\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 80\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleolysin tia-1 (rna-binding protein tia-1) (p40-tia-1) [contains: p15-tia-1]. [source:swissprot;acc:p31483]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4133.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5945.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.43834\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 81\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleolysin tiar (tia-1 related protein). [source:swissprot;acc:q01085]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4136.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5943.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.43691\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 82\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent small nuclear ribonucleoprotein sm d1 (snrnp core protein d1) (sm-d1) (sm-d autoantigen). [source:swissprot;acc:p13641]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4172.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5954.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.42694\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 83\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent proto-oncogene protein c-fos (cellular oncogene fos) (g0/g1 switch regulatory protein 7). [source:swissprot;acc:p01100]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4932.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7033.29\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.42597\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 84\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent jun dimerization protein. [source:refseq;acc:nm\_130469]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 85\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4941.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7037.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.42395\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 86\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein fosb (g0/g1 switch regulatory protein 3). [source:swissprot;acc:p53539]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4942.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7037.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.42384\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 87\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent fos-related antigen 1 (fra-1). [source:swissprot;acc:p15407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4944.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7038.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.42347\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 88\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent potassium voltage-gated channel, shal-related subfamily, member 2; voltage-sensitive potassium channel; voltage-gated potassium channel kv4.2. [source:refseq;acc:nm\_012281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2411.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1695.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.42259\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 89\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cystathionine gamma-lyase (ec 4.4.1.1) (gamma-cystathionase). [source:swissprot;acc:p32929]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2414.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1698.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.4217\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 90\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent potassium voltage-gated channel, shal-related subfamily, member 3 isoform 1; sha1-related potassium channel kv4.3; voltage-gated k+ channel; potassium ionic channel kv4.3; voltage-gated potassium channel kv4.3. [source:refseq;acc:nm\_004980]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2414.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1698.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.4215\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 91\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent potassium voltage-gated channel, shal-related subfamily, member 1; shal-type potassium channel; voltage-gated potassium channel kv4.1. [source:refseq;acc:nm\_004979]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2416.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1700.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.42082\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 92\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dj820b18.1 (similar to nuclear cap binding protein) (fragment). [source:sptrembl;acc:q8wwk2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4117.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5801.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.40882\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 93\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent formin binding protein 3; fas-ligand associated factor 1; huntingtin-interacting protein a; ny-ren-6 antigen. [source:refseq;acc:nm\_017892]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4245.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5942.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.39977\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 94\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent huntingtin-interacting protein hypa/fbp11 (fragment). [source:sptrembl;acc:o75404]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4247.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5941.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.39879\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 95\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent son protein (son3) (negative regulatory element-binding protein) (nre- binding protein) (dbp-5) (bax antagonist selected in saccharomyces 1) (bass1) (protein c21orf50). [source:swissprot;acc:p18583]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2397.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3343.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.39481\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 96\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lag1 longevity assurance homolog 2 isoform 1; l3 pigment; tumor metastasis-suppressor. [source:refseq;acc:nm\_022075]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4110.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5694.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.3856\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 97\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent amyloid beta a4 precursor protein-binding family a member 1 (neuron- specific x11 protein) (neuronal munc18-1-interacting protein 1) (mint-1) (adapter protein x11alpha). [source:swissprot;acc:q02410]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2820.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3897.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.3817\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 98\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent presenilin 2 (ps-2) (stm-2) (e5-1) (ad3lp) (ad5). [source:swissprot;acc:p49810]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 2353.63\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 3225.65\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.3705\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 99\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent s-phase kinase-associated protein 1a (cyclin a/cdk2-associated protein p19) (p19a) (p19skp1) (rna polymerase ii elongation factor-like protein) (organ of corti protein 2) (ocp-ii protein) (ocp-2) (transcription elongation factor b) (siii). [source:swissprot;acc:p34991]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 100\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent f-box protein fbw7 isoform 2; archipelago, drosophila, homolog of; f-box protein fbw7; f-box protein sel-10; homolog of c elegans sel-10. [source:refseq;acc:nm\_018315]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 101\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cullin homolog 2 (cul-2). [source:swissprot;acc:q13617]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 102\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent presenilin 1 (ps-1) (s182 protein). [source:swissprot;acc:p49768]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 103\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cullin homolog 1 (cul-1). [source:swissprot;acc:q13616]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent musashi 2 isoform a. [source:refseq;acc:nm\_138962]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4241.57\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5810.79\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.36996\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 105\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent musashi 1. [source:refseq;acc:nm\_002442]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nuclear protein ukp68. [source:refseq;acc:nm\_024824]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 107\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 20 kda nuclear cap binding protein (ncbp 20 kda subunit) (cbp20) (ncbp interacting protein 1) (nip1). [source:swissprot;acc:p52298]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4266.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5843.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.36977\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 108\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent filamin b, beta (actin binding protein 278); beta filamin; filamin 1 (actin-binding protein-280)-like; filamin b, beta (actin-binding protein-278); filamin b, beta. [source:refseq;acc:nm\_001457]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4366.44\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5899.76\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.35116\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 109\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rev1-like; rev1 protein; rev1 (yeast homolog)- like. [source:refseq;acc:nm\_016316]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 110\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein arginine n-methyltransferase 1 (ec 2.1.1.-) (interferon receptor 1-bound protein 4). [source:swissprot;acc:q99873]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 111\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein arginine n-methyltransferase 4 (ec 2.1.1.-). [source:swissprot;acc:q9nr22]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 112\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent u1 small nuclear ribonucleoprotein 70 kda (u1 snrnp 70 kda) (snrnp70) (u1-70k). [source:swissprot;acc:p08621]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 113\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent filamin a (alpha-filamin) (filamin 1) (endothelial actin-binding protein) (abp-280) (nonmuscle filamin). [source:swissprot;acc:p21333]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 114\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent huntingtin interacting protein c. [source:refseq;acc:nm\_012272]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4300.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5807.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.35048\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 115\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 21185\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 28492\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.34491\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 116\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 117\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 118\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 119\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 120\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent high-mobility group 20b; sox-like transcriptional factor; swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily e, member 1-related. [source:refseq;acc:nm\_006339]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5136.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6895.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.34247\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 121\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription factor jun-b. [source:swissprot;acc:p17275]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5579.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7488.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.3422\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 122\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent high-mobility group 20a. [source:refseq;acc:nm\_018200]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5140.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6893.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.34112\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 123\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 24260.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 18172.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.33503\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 124\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent microtubule-associated proteins 1a/1b light chain 3b (map1a/map1b lc3 b) (map1a/1b light chain 3 b). [source:swissprot;acc:q9gzq8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 24255.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 18168.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.33501\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 125\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent microtubule-associated proteins 1a/1b light chain 3a (map1a/map1b lc3 a) (map1a/1b light chain 3 a). [source:swissprot;acc:q9h492]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 126\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 24250\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 18164.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.33499\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/